EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1

Sonali Mishra, Pamela Kell, David Scherrer, Dennis J Dietzen, Charles H Vite, Elizabeth Berry-Kravis, Cristin Davidson, Stephanie M Cologna, Forbes D Porter, Daniel S Ory, Xuntian Jiang

Journal of Lipid Research · 2024

DOI: 10.1016/j.jlr.2024.100600 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Lipid Research, 2024. Verfasst von Sonali Mishra und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA. Hauptthemen laut MEDLINE: Niemann-Pick Disease, Type C, Lysophosphatidylcholines. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lysosomal function is impaired in Niemann-Pick disease type C1 (NPC1), a rare and inherited neurodegenerative disorder, resulting in late endosomal/lysosomal accumulation of unesterified cholesterol. The precise pathogenic mechanism of NPC1 remains incompletely understood. In this study, we employed metabolomics to uncover secondary accumulated substances in NPC1. Our findings unveiled a substantial elevation in the levels of three alkyl-lysophosphatidylcholine [alkyl-LPC, also known as lyso-platelet activating factor (PAF)] species in NPC1 compared to controls across various tissues, including brain tissue from individuals with NPC1, liver, spleen, cerebrum, cerebellum, and brain stem from NPC1 mice, as well as in both brain and liver tissue from NPC1 cats. The three elevated alkyl-LPC species were as follows: LPC O-16:0, LPC O-18:1, and LPC O-18:0. However, the levels of PAF 16:0, PAF 18:1, and PAF 18:0 were not altered in NPC1. In the NPC1 feline model, the brain and liver alkyl-LPC levels were reduced following 2-hydroxypropyl-β-cyclodextrin (HPβCD) treatment, suggesting that alkyl-LPCs are secondary storage metabolites in NPC1 disease. Unexpectedly, cerebrospinal fluid (CSF) levels of LPC O-16:0 and LPC O-18:1 were decreased in individuals with NPC1 compared to age-appropriate comparison samples, and their levels were increased in 80% of participants 2 years after intrathecal HPβCD treatment. The fold increases in CSF LPC O-16:0 and LPC O-18:1 levels were more pronounced in responders compared to nonresponders. This study identified alkyl-LPC species as secondary storage metabolites in NPC1 and indicates that LPC O-16:0 and LPC O-18:1, in particular, could serve as potential biomarkers for tracking treatment response in NPC1 patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Niemann-Pick Disease, Type CLysophosphatidylcholinesAnimalsCatsMiceHumansMaleFemaleBrain2-Hydroxypropyl-beta-cyclodextrinChildAdultLiverAdolescentChild, Preschoolbeta-Cyclodextrins

Stichwörter der Autor:innen

Niemann-Pick disease type Calkyl-lysophosphatidylcholinebiomarkermass spectrometrystructural identification

Substanzen

Lysophosphatidylcholines2-Hydroxypropyl-beta-cyclodextrinbeta-Cyclodextrins

Autor:innen und Institutionen

  • Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
  • Department of Clinical Studies and Advanced Medicine, University of Pennsylvania School of Veterinary Medicine, PA, USA.
  • Department of Pediatrics, Neurological Sciences and Anatomy and Cell Biology, Rush University Medical Center, Chicago, IL, USA.
  • Section on Molecular Dysmorphology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS, Bethesda, MD, USA.
  • Department of Chemistry, University of Illinois Chicago, Chicago, IL, USA.

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Mishra, S., Kell, P., Scherrer, D., Dietzen, D. J., Vite, C. H., Berry-Kravis, E., Davidson, C., Cologna, S. M., Porter, F. D., Ory, D. S., & Jiang, X. (2024). Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1. Journal of Lipid Research. https://doi.org/10.1016/j.jlr.2024.100600

Vancouver

Mishra S, Kell P, Scherrer D, Dietzen DJ, Vite CH, Berry-Kravis E, et al. Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1. Journal of Lipid Research. 2024. doi:10.1016/j.jlr.2024.100600

BibTeX
@article{Mishra2024,
  author = {Mishra, Sonali and Kell, Pamela and Scherrer, David and Dietzen, Dennis J and Vite, Charles H and Berry-Kravis, Elizabeth and Davidson, Cristin and Cologna, Stephanie M and Porter, Forbes D and Ory, Daniel S and Jiang, Xuntian},
  title = {Accumulation of alkyl-lysophosphatidylcholines in Niemann-Pick disease type C1},
  journal = {Journal of Lipid Research},
  year = {2024},
  doi = {10.1016/j.jlr.2024.100600}
}
Kostenlos starten →